Aceto Corp. has begun selling a generic drug used to treat dry mouth, the Port Washington-based company announced.

The drug, cevimeline hydrochloride, is an alternative to the brand-name Evoxac from the Japanese pharmaceutical giant, Daiichi Sankyo Inc. The market for the generic is estimated to be about $56 million per year, according to the IMS Health data service.

Cevimeline hydrochloride is being sold by Aceto's Rising Pharmaceuticals division and is the fifth drug it has launched this year.

NewsdayTV's Doug Geed is heading 'Out East' to showcase the ultimate local spots you need to explore.

Out East Show: Westhampton Beach Brew & Grille, Hallockville Museum Farm Bees, North Fork Foodie Tour, Southampton Animal Shelter Foundation NewsdayTV's Doug Geed is heading 'Out East' to showcase the ultimate local spots you need to explore.

NewsdayTV's Doug Geed is heading 'Out East' to showcase the ultimate local spots you need to explore.

Out East Show: Westhampton Beach Brew & Grille, Hallockville Museum Farm Bees, North Fork Foodie Tour, Southampton Animal Shelter Foundation NewsdayTV's Doug Geed is heading 'Out East' to showcase the ultimate local spots you need to explore.

SUBSCRIBE

Unlimited Digital AccessOnly 25¢for 6 months

ACT NOWSALE ENDS SOON | CANCEL ANYTIME